Articles

Results 1 to 5 of 5
Most popular |Most recent


Spotlight: competition law in the pharmaceutical sector in Canada

Canada - October 6 2020 This article reviews the application of competition law principles to the pharmaceutical sector in Canada, with particular regard to the merger control regime and anticompetitive behaviour.

Erin Brown, Kevin Ackhurst, Stephen Nattrass.

A general introduction to pharmaceutical IP and competition issues in Canada

Canada - October 6 2020 This article examines the most consequential features of the IP and competition law frameworks in relation to the pharmaceutical sector in Canada, with particular regard to recent developments.

Erin Brown, Kevin Ackhurst, Stephen Nattrass.

In brief: anticompetitive agreements in the pharmaceutical sector in Canada

Canada - June 30 2020 The essential legal considerations surrounding anticompetitive agreements in the pharmaceutical sector in Canada, including the assessment framework and special issues with vertical agreements.

Erin Brown, Kevin Ackhurst, Stephen Nattrass.

At a glance: pharmaceutical merger review in Canada

Canada - June 30 2020 This article looks at some of the key legal and practical issues surrounding the competition authorities' review of mergers in the pharmaceutical sector in Canada, including review triggers and thresholds.

Erin Brown, Kevin Ackhurst, Stephen Nattrass.

Snapshot: anticompetitive unilateral conduct in the pharmaceutical sector in Canada

Canada - June 30 2020 A look at key practical considerations surrounding abuse of dominance and other anticompetitive unilateral conduct in the pharmaceutical sector in Canada, including IP rights abuse and pricing conduct.

Erin Brown, Kevin Ackhurst, Stephen Nattrass.